IDRI wins BARDA adjuvant development contract
IDRI is developing adjuvant formulations to support sustainable production of pandemic influenza vaccines after being awarded a BARDA contract.
IDRI is developing adjuvant formulations to support sustainable production of pandemic influenza vaccines after being awarded a BARDA contract.
Prometheus Laboratories is performing mutational analyses on clinical samples from Bayer Schering Pharma as part of an extended services agreement.
The Partnership for Safe Medicines (PSM) has established a presence in India to bring together local stakeholders and protect consumers from counterfeit medicines.
Bulgarian drugmaker Sopharma will invest BGN70m ($47m) in the construction of a new manufacturing plant in a further bid to drive export growth.
US CDMO DPT Laboratories has received FDA approval to make commercial supplies of a wound ointment at its sterile and specialty products plant in Lakewood, New Jersey.